Centers for disease control 'high-risk' donors and kidney utilization

American Journal of Transplantation

Volumn 10, Issue 2, 2010, Pages 416-420

  Duan, K I ^a   Englesbe, M J ^a   Volk, M L ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Disease transmission; Extended criteria donors; Kidney transplantation; Organ donation; Organ utilization

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE UTILIZATION; HIGH RISK BEHAVIOR; HUMAN; KIDNEY; KIDNEY TRANSPLANTATION; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PUBLIC HEALTH SERVICE;

EID: 75149156952     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02931.x     Document Type: Article

References (14)

1. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994 43 : 1 17.
2. Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant 2009 9 : 629 635.
3. Ison MG, Hager J, Blumberg E et al. Donor-derived disease transmission events in the United States: Data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009 9 : 1929 1935.
4. Ahn J, Cohen SM. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2008 14 : 1603 1608.
5. UNOS. OPTN/UNOS Policy 4: Acquired Immune Deficiency Syndrome (AIDS) and Human Pituitary Derived Growth Hormone. 2009 Available at : http://www.unos.org/ PoliciesandBylaws2/policies/pdfs/policy-16.pdf. Accessed November 10, 2009.
6. Halpern SD, Shaked A, Hasz RD, Caplan AL. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008 358 : 2832 2837.
7. Allison PD. Missing data. Thousand Oaks, CA : Sage Publications, 2002.
8. Wolfe RA, LaPorte FB, Rodgers AM, Roys EC, Fant G, Leichtman AB. Developing organ offer and acceptance measures: When 'good' organs are turned down. Am J Transplant 2007 7 (5 Pt 2 1404 1411.
9. SRTR. Risk-adjustment models. 2009. Available at : http://www. ustransplant.org. Accessed November 10, 2009.
10. Reese PP, Feldman HI, Asch DA et al. Transplantation of kidneys from donors at increased risk for blood-borne viral infection: Recipient outcomes and patterns of organ use. Am J Transplant 2009 9 : 2338 2345.
11. Kahneman D, Slovic P, Tversky A. Judgment under uncertainty: Heuristics and biases. Cambridge, New York : Cambridge University Press, 1982.
12. Fagerlin A, Ubel PA, Smith DM, Zikmund-Fisher BJ. Making numbers matter: Present and future research in risk communication. Am J Health Behav 2007 31 (Suppl 1 S47 56.
13. Zikmund-Fisher BJ, Fagerlin A, Roberts TR, Derry HA, Ubel PA. Alternate methods of framing information about medication side effects: Incremental risk versus total risk of occurrence. J Health Commun 2008 13 : 107 124.
14. Fagerlin A, Zikmund-Fisher BJ, Ubel PA. "If I'm better than average, then I'm ok?": Comparative information influences beliefs about risk and benefits. Patient Educ Couns 2007 69 : 140 144.